Your browser doesn't support javascript.
loading
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).
Bonaca, Marc P; Nault, Patrice; Giugliano, Robert P; Keech, Anthony C; Pineda, Armando Lira; Kanevsky, Estella; Kuder, Julia; Murphy, Sabina A; Jukema, J Wouter; Lewis, Basil S; Tokgozoglu, Lale; Somaratne, Ransi; Sever, Peter S; Pedersen, Terje R; Sabatine, Marc S.
Affiliation
  • Bonaca MP; Thrombolysis In Myocardial Infarction Study Group, Brigham and Women's Hospital Heart & Vascular Center, Boston, MA (M.P.B., R.P.G., E.K., J.K., M.S.S.) mbonaca@partners.org.
  • Nault P; McGill University, Montreal, and Division of Vascular and Endovascular Surgery, Centre Intégré de la santé et des services sociaux de l'Outaouais, Gatineau, Canada (P.N.).
  • Giugliano RP; Thrombolysis In Myocardial Infarction Study Group, Brigham and Women's Hospital Heart & Vascular Center, Boston, MA (M.P.B., R.P.G., E.K., J.K., M.S.S.).
  • Keech AC; Sydney Medical School, National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Australia (A.C.K.).
  • Pineda AL; Amgen, Thousand Oaks, CA (A.L.P., R.S.).
  • Kanevsky E; Thrombolysis In Myocardial Infarction Study Group, Brigham and Women's Hospital Heart & Vascular Center, Boston, MA (M.P.B., R.P.G., E.K., J.K., M.S.S.).
  • Kuder J; Thrombolysis In Myocardial Infarction Study Group, Brigham and Women's Hospital Heart & Vascular Center, Boston, MA (M.P.B., R.P.G., E.K., J.K., M.S.S.).
  • Jukema JW; Department of Cardiology, Leiden University Medical Center, the Netherlands (J.W.J.).
  • Lewis BS; Lady Davis Carmel Medical Center and Ruth and Bruce Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel (B.S.L.).
  • Tokgozoglu L; Department of Cardiology, Hacettepe University, Ankara, Turkey (L.T.).
  • Somaratne R; Amgen, Thousand Oaks, CA (A.L.P., R.S.).
  • Sever PS; International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, UK (P.S.S.).
  • Pedersen TR; Oslo University Hospital, Ullevål and Medical Faculty, University of Oslo, Norway (T.R.P.).
  • Sabatine MS; Thrombolysis In Myocardial Infarction Study Group, Brigham and Women's Hospital Heart & Vascular Center, Boston, MA (M.P.B., R.P.G., E.K., J.K., M.S.S.).
Circulation ; 137(4): 338-350, 2018 01 23.
Article in En | MEDLINE | ID: mdl-29133605
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Serine Proteinase Inhibitors / Dyslipidemias / Peripheral Arterial Disease / PCSK9 Inhibitors / Cholesterol, LDL / Antibodies, Monoclonal / Anticholesteremic Agents Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Circulation Year: 2018 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Serine Proteinase Inhibitors / Dyslipidemias / Peripheral Arterial Disease / PCSK9 Inhibitors / Cholesterol, LDL / Antibodies, Monoclonal / Anticholesteremic Agents Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Circulation Year: 2018 Type: Article